Trial intelligence / Profile preview

Evaluation of topical ASF-1075 in chronic hand dermatitis

2005-005793-75Phase 2Completed

Sponsor
Astion Pharma
Start
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in chronic hand dermatitis (CHE) and hand dermatitis comparing ASF-1075 topical formulation with Active-ingredient-free vehicle (2 arms). Primary endpoint: Clinical assessment by HECSI. Started Jan 2006; status: completed.

02

Drugs

ASF-1075
03

Conditions

chronic hand dermatitis (CHE)hand dermatitis

Beyond the preview

Go deeper on 2005-005793-75.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005793-75.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call